Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

BANMINTH II DIN 00327042

Status: Marketed
Holder: PHIBRO ANIMAL HEALTH CORPORATION
Molecule: MORANTEL TARTRATE

Health Canada record

Active ingredient(s)MORANTEL TARTRATE 200 G
Dosage formDrug Premix
RouteOral
ScheduleNON-PRESCRIPTION DRUGS
ClassVeterinary
ATC
Original market date31-Dec-1977
Current status date21-Jul-2010
SourceHealth Canada DPD

Establishment licence of the holder

Phibro Animal Health Ltd. — licence 3-002901, currently licensed, last inspection rating I (2026-06-23).

No Canadian shortage report is currently matched to this DIN.

Other Canadian products containing MORANTEL TARTRATE

DINProductCompanyFormStrengthStatus
00660426BANMINTH II DEWORMER PELLETSPFIZER CANADA ULCDrug PremixMORANTEL TARTRATE 10 GCancelled Post Market
00666262CATTLE HOG WORMER PELLETS W MORANTEL 1%NEW-LIFE MILLS LTD.Drug PremixMORANTEL TARTRATE 10 GCancelled Post Market
00782254CO-OP BANMINTH II DEWORMER PELLETSINTERPROVINCIAL CO-OP LTDDrug PremixMORANTEL TARTRATE 10 GCancelled Post Market
00597813EXHELM E DAIRY & BEEF CATTLE WORMERROGAR/STB INC.TabletMORANTEL TARTRATE 2.5 GCancelled Post Market
00655414EXHELM E PELLETS 10GM/KGROGAR/STB INC.Drug PremixMORANTEL TARTRATE 10 GCancelled Post Market
00809268PURINA BANMINTH II 10GM/KGRALSTON PURINA CANADA INC.Drug PremixMORANTEL TARTRATE 10 GCancelled Post Market

Notices of Compliance

NOCDateSubmissionReason
116032010-07-20New Drug Submission (NDS)Change in ownership
61222002-04-10New Drug Submission (NDS)
Request a quote for BANMINTH II

How to read a Canadian DIN record